At the news
? NEUTRALIMPACT 2/10 3 filed Jul 1, 2026 at 18:48 ET
HRT Financial LP filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 71,842 shares of Shuttle Pharmaceuticals common stock. This is a routine disclosure with no transaction or material change in ownership.
- HRT Financial LP reported beneficial ownership of 71,842 shares of common stock as of June 29, 2026.
- Form 3 is an initial statement of beneficial ownership, not a transaction filing.
- No changes in ownership or new transactions were disclosed.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access